3172 results for «278»
3172 results
Management of coronary aneurysms
18 Dec 2024 – From GulfPCR-GIM 2024
Explore this session to discover innovative approaches to the management of complex coronary aneurysms. From contrast-induced nephropathy prevention using a balloon angiography system to rescue techniques for wire fracture during atherectomy, you'll gain insights into navigating challenging scenarios. Dive deeper into the percutaneous exclusion of a...
Optimisation of immediate and long-term outcomes using a novel self-expanding valve
18 Dec 2024 – From GulfPCR-GIM 2024
Explore the features and benefits of the ACURATE neo2, a novel self-expanding valve, through clinical cases and recorded procedures. Gain insights into step-by-step implantation techniques, the latest evidence in TAVI, and outcomes from immediate to long-term, focusing on lifetime patient management.
Wireless physiology assessment
22 May 2025 – From EuroPCR 2025
This session examines the evolving field of wireless physiology assessment in PCI. Topics include randomized trials comparing angiography and physiology guidance, prognostic performance of imaging-derived physiology, and outcomes in various patient subsets including elderly patients with multivessel disease.
Beyond angiography: imaging-guided solutions for stent failure
22 May 2025 – From EuroPCR 2025
Stent failure remains a critical challenge in interventional cardiology — but intracoronary imaging can change the outcome. This session goes beyond angiography to examine why stents fail, how to detect underlying causes, and how imaging-guided strategies can help tailor reintervention. Two real-life cases, from complex restenosis...
Complications in STEMI : dissections and more
21 May 2025 – From EuroPCR 2025
Address complications encountered in STEMI interventions such as dissections and coronary perforations. Learn from case presentations highlighting procedural challenges, management of delayed perforations, and balancing procedural perfection with practical outcomes.
OHCM, ablation complications: interventional solutions
21 May 2025 – From EuroPCR 2025
Explore interventional solutions for complications arising in obstructive hypertrophic cardiomyopathy (OHCM) and ablation procedures. Cases include complex congenital anomalies, novel non-invasive treatments, dual pulmonary vein stenosis, iatrogenic fistulas, and ablation-related cardiac defects.
Calcium modification: contemporary comparaisons of atherectomy and IVL
22 May 2025 – From EuroPCR 2025
Compare contemporary calcium modification techniques including atherectomy and intravascular lithotripsy (IVL) in complex coronary lesions. Review clinical outcomes, procedural case studies, and registry data highlighting safety and efficacy in acute coronary syndrome and high-risk patients.
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
